Trifecta Capital Advisors, LLC Pfizer Inc Transaction History
Trifecta Capital Advisors, LLC
- $658 Billion
- Q3 2025
A detailed history of Trifecta Capital Advisors, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Trifecta Capital Advisors, LLC holds 647 shares of PFE stock, worth $16,226. This represents 0.0% of its overall portfolio holdings.
Number of Shares
647
Previous 3,697
82.5%
Holding current value
$16,226
Previous $89.6 Million
81.6%
% of portfolio
0.0%
Previous 0.01%
Shares
11 transactions
Others Institutions Holding PFE
# of Institutions
3,354Shares Held
3.57BCall Options Held
87.2MPut Options Held
106M-
Vanguard Group Inc Valley Forge, PA534MShares$13.4 Billion0.21% of portfolio
-
Black Rock Inc. New York, NY424MShares$10.6 Billion0.27% of portfolio
-
State Street Corp Boston, MA299MShares$7.5 Billion0.27% of portfolio
-
Geode Capital Management, LLC Boston, MA129MShares$3.24 Billion0.22% of portfolio
-
Morgan Stanley New York, NY74.8MShares$1.88 Billion0.12% of portfolio
About PFIZER INC
- Ticker PFE
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 5,612,349,952
- Market Cap $141B
- Description
- Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...